DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02552 HUA MEDICINE-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders ARCH Venture Partners VII, LLC (11.85%)
Venrock Associates V, L.P. (9.80%)
The Core Trust Company Limited (9.00%)		 Sector Health Care & Biotechnology
Web Site http://www.huamedicine.com Tel (86 21) 3810-1800
Email ir@huamedicine.com Fax (86 21) 3810-1808
Related Equities N/A
Principal Activities Principally engaged in the development and commercialization of a global firstin-class oral drug, dorzagliatin or HMS5552, for the treatment of diabetes.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Bybee Clinton Whitewood 125,088,960(L)  11.89(L)  14/09/2018
Crandell Keith Lawrence 125,088,960(L)  11.89(L)  14/09/2018
Nelsen Robert Taylor 125,088,960(L)  11.89(L)  14/09/2018
The Core Trust Company Limited 117,000,000(L)  11.12(L)  14/09/2018
Pandanus Associates Inc. 107,686,470(L)  10.24(L)  14/09/2018
Pandanus Partners L.P. 107,686,470(L)  10.24(L)  14/09/2018
FMR LLC 105,581,040(L)  10.04(L)  14/09/2018
Johnson Abigail P. 105,581,040(L)  10.04(L)  14/09/2018
Johnson IV Edward C. 105,581,040(L)  10.04(L)  14/09/2018
Venrock Management V, LLC 103,475,595(L)  9.84(L)  14/09/2018
WuXi AppTec Co., Ltd. 74,029,635(L)  7.02(L)  13/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Nelsen Robert Taylor 125,088,960(L)  11.89(L)  14/09/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top